<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31680172</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>22</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>16</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res</ISOAbbreviation></Journal><ArticleTitle>Targeted DNA methylation of neurodegenerative disease genes via homology directed repair.</ArticleTitle><Pagination><StartPage>11609</StartPage><EndPage>11622</EndPage><MedlinePgn>11609-11622</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkz979</ELocationID><Abstract><AbstractText>DNA methyltransferases (DNMTs) are thought to be involved in the cellular response to DNA damage, thus linking DNA repair mechanisms with DNA methylation. In this study we present Homology Assisted Repair Dependent Epigenetic eNgineering (HARDEN), a novel method of targeted DNA methylation that utilizes endogenous DNA double strand break repair pathways. This method allows for stable targeted DNA methylation through the process of homology directed repair (HDR) via an in vitro methylated exogenous repair template. We demonstrate that HARDEN can be applied to the neurodegenerative disease genes C9orf72 and APP, and methylation can be induced via HDR with both single and double stranded methylated repair templates. HARDEN allows for higher targeted DNA methylation levels than a dCas9-DNMT3a fusion protein construct at C9orf72, and genome-wide methylation analysis reveals no significant off-target methylation changes when inducing methylation via HARDEN, whereas the dCas9-DNMT3a fusion construct causes global off-target methylation. HARDEN is applied to generate a patient derived iPSC model of amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD) that recapitulates DNA methylation patterns seen in patients, demonstrating that DNA methylation of the 5' regulatory region directly reduces C9orf72 expression and increases histone H3K9 tri-methylation levels.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cali</LastName><ForeName>Christopher P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Translational Neuropathology Research Laboratory, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Translational Neuropathology Research Laboratory, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Edward B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Translational Neuropathology Research Laboratory, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS095793</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C545487">APP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006657">Histones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017394">RNA, Guide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.1.1.-</RegistryNumber><NameOfSubstance UI="D015257">DNA-Cytosine Methylases</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064113" MajorTopicYN="N">CRISPR-Cas Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053903" MajorTopicYN="N">DNA Breaks, Double-Stranded</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015257" MajorTopicYN="N">DNA-Cytosine Methylases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055786" MajorTopicYN="N">Gene Knockout Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015894" MajorTopicYN="N">Genome, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006657" MajorTopicYN="N">Histones</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017394" MajorTopicYN="N">RNA, Guide, Kinetoplastida</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31680172</ArticleId><ArticleId IdType="pmc">PMC7145628</ArticleId><ArticleId IdType="doi">10.1093/nar/gkz979</ArticleId><ArticleId IdType="pii">5611673</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sch&#xfc;beler D. Function and information content of DNA methylation. Nature. 2015; 517:321&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">25592537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lardenoije R., Iatrou A., Kenis G., Kompotis K., Steinbusch H.W.M., Mastroeni D., Coleman P., Lemere C.A., Hof P.R., van&#xa0;den&#xa0;Hove D.L.A. et al. .. The epigenetics of aging and neurodegeneration. Prog. Neurobiol. 2015; 131:21&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6477921</ArticleId><ArticleId IdType="pubmed">26072273</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z., Rainero I., Rubino E., Pinessi L., Bruni A.C., Maletta R.G., Nacmias B., Sorbi S., Galimberti D., Surace E.I. et al. .. Hypermethylation of the CpG-island near the C9orf72 G4C2-repeat expansion in FTLD patients. Hum. Mol. Genet. 2014; 23:5630&#x2013;5637.</Citation><ArticleIdList><ArticleId IdType="pubmed">24908669</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu E.Y., Russ J., Wu K., Neal D., Suh E., McNally A.G., Irwin D.J., Van&#xa0;Deerlin V.M., Lee E.B.. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD. Acta Neuropathol. 2014; 128:525&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4161616</ArticleId><ArticleId IdType="pubmed">24806409</ArticleId></ArticleIdList></Reference><Reference><Citation>Russ J., Liu E.Y., Wu K., Neal D., Suh E.R., Irwin D.J., McMillan C.T., Harms M.B., Cairns N.J., Wood E.M. et al. .. Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathol. 2015; 129:39&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4282973</ArticleId><ArticleId IdType="pubmed">25388784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E.A., Bieniek K.F., Gendron T.F., Caulfield T., Lin W.L., DeJesus-Hernandez M., Van&#xa0;Blitterswijk M.M., Jansen-West K., Paul J.W., Rademakers R. et al. .. Unconventional translation of C9ORF72 GGGGCC Expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013; 77:639&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D., O&#x2019;Rourke J.G., Meera P., Muhammad A.K.M.G., Grant S., Simpkinson M., Bell S., Carmona S., Ornelas L., Sahabian A. et al. .. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med. 2013; 5:208ra149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly C.J., Zhang P., Pham J.T., Haeusler A.R., Mistry N.A., Vidensky S., Daley E.L., Poth E.M., Hoover B., Fines D.M. et al. .. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013; 80:415&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S., Gascon E., Tran H., Chou H.J., Gendron T.F., Degroot S., Tapper A.R., Sellier C., Charlet-Berguerand N., Karydas A. et al. .. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 2013; 126:385&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3753484</ArticleId><ArticleId IdType="pubmed">23836290</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I., Xiang S., Kato M., Wu L., Theodoropoulos P., Wang T., Kim J., Yun J., Xie Y., McKnight S.L.. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science. 2014; 345:1139&#x2013;1145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.B., Chen H.J., Peres J.N., Gomez-Deza J., Attig J., &#x160;talekar M., Troakes C., Nishimura A.L., Scotter E.L., Vance C. et al. .. Hexanucleotide repeats in ALS/FTD form length-dependent RNA Foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 2013; 5:1178&#x2013;1186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898469</ArticleId><ArticleId IdType="pubmed">24290757</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, Gendron T.F., Prudencio M., Sasaguri H., Zhang Y.J., Castanedes-Casey M., Lee C.W., Jansen-West K., Kurti A., Murray M.E. et al. .. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science. 2015; 348:1151&#x2013;1154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4692360</ArticleId><ArticleId IdType="pubmed">25977373</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke J.G., Bogdanik L., Muhammad A.K.M.G., Gendron T.F., Kim K.J., Austin A., Cady J., Liu E.Y., Zarrow J., Grant S. et al. .. C9orf72 BAC Transgenic mice display typical pathologic features of ALS/FTD. Neuron. 2015; 88:892&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan C.T., Russ J., Wood E.M., Irwin D.J., Grossman M., McCluskey L., Elman L., Van&#xa0;Deerlin V., Lee E.B.. C9orf72 promoter hypermethylation is neuroprotective: Neuroimaging and neuropathologic evidence. Neurology. 2015; 84:1622&#x2013;1630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409587</ArticleId><ArticleId IdType="pubmed">25795648</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojta A., Dobrinic P., Tadic V., Bockor L., Korac P., Julg B., Klasic M., Zoldos V.. Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Res. 2016; 44:5615&#x2013;5628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4937303</ArticleId><ArticleId IdType="pubmed">26969735</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y., Zhang X., Su J., Jeong M., Gundry M.C., Huang Y.H., Zhou Y., Li W., Goodell M.A.. Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein. Nat. Commun. 2017; 8:16026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5508226</ArticleId><ArticleId IdType="pubmed">28695892</ArticleId></ArticleIdList></Reference><Reference><Citation>Pflueger C., Tan D., Swain T., Nguyen T., Pflueger J., Nefzger C., Polo J.M., Ford E., Lister R.. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs. Genome Res. 2018; 28:1193&#x2013;1206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6071642</ArticleId><ArticleId IdType="pubmed">29907613</ArticleId></ArticleIdList></Reference><Reference><Citation>Galonska C., Charlton J., Mattei A.L., Donaghey J., Clement K., Gu H., Mohammad A.W., Stamenova E.K., Cacchiarelli D., Klages S. et al. .. Genome-wide tracking of dCas9-methyltransferase footprints. Nat. Commun. 2018; 9:597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5807365</ArticleId><ArticleId IdType="pubmed">29426832</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong T., Meister G.E., Workman R.E., Kato N.C., Spellberg M.J., Turker F., Timp W., Ostermeier M., Novina C.D.. Targeted DNA methylation in human cells using engineered dCas9-methyltransferases. Sci. Rep. 2017; 7:6732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5532369</ArticleId><ArticleId IdType="pubmed">28751638</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Liu Y., Xu F., Huang J., Daugaard T.F., Petersen T.S., Hansen B., Ye L., Zhou Q., Fang F. et al. .. Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases. Gigascience. 2018; 7:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5888497</ArticleId><ArticleId IdType="pubmed">29635374</ArticleId></ArticleIdList></Reference><Reference><Citation>Falahi F., Sgro A., Blancafort P.. Epigenome engineering in cancer: Fairytale or a realistic path to the clinic. Front. Oncol. 2015; 5:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4319383</ArticleId><ArticleId IdType="pubmed">25705610</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepper P., Kungulovski G., Jurkowska R.Z., Chandra T., Krueger F., Reinhardt R., Reik W., Jeltsch A., Jurkowski T.P.. Efficient targeted DNA methylation with chimeric dCas9-Dnmt3a-Dnmt3L methyltransferase. Nucleic Acids Res. 2017; 45:1703&#x2013;1713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5389507</ArticleId><ArticleId IdType="pubmed">27899645</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue K., Oliveira L.M.A., Abeliovich A.. CRISPR Transcriptional activation analysis unmasks an Occult &#x3b3;-Secretase processivity defect in familial alzheimer's disease skin fibroblasts. Cell Rep. 2017; 21:1727&#x2013;1736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5704930</ArticleId><ArticleId IdType="pubmed">29141208</ArticleId></ArticleIdList></Reference><Reference><Citation>Kungulovski G., Nunna S., Thomas M., Zanger U.M., Reinhardt R., Jeltsch A.. Targeted epigenome editing of an endogenous locus with chromatin modifiers is not stably maintained. Epigenet.Chromatin. 2015; 8:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4404288</ArticleId><ArticleId IdType="pubmed">25901185</ArticleId></ArticleIdList></Reference><Reference><Citation>Amabile A., Migliara A., Capasso P., Biffi M., Cittaro D., Naldini L., Lombardo A.. Inheritable silencing of endogenous genes by Hit-and-Run targeted epigenetic editing. Cell. 2016; 167:219&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5039111</ArticleId><ArticleId IdType="pubmed">27662090</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyama T., Wilson D.M.. DNA repair mechanisms in dividing and non-dividing cells. DNA Repair (Amst). 2013; 12:620&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3720834</ArticleId><ArticleId IdType="pubmed">23684800</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour W.Y., Schumacher S., Rosskopf R., Rhein T., Schmidt-Petersen F., Gatzemeier F., Haag F., Borgmann K., Willers H., Dahm-Daphi J.. Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks. Nucleic Acids Res. 2008; 36:4088&#x2013;4098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2475611</ArticleId><ArticleId IdType="pubmed">18539610</ArticleId></ArticleIdList></Reference><Reference><Citation>San&#xa0;Filippo J., Sung P., Klein H.. Mechanism of eukaryotic homologous recombination. Annu. Rev. Biochem. 2008; 77:229&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">18275380</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama A., Yamaguchi L., Nakanishi M.. Regulation of maintenance DNA methylation via histone ubiquitylation. J. Biochem. 2016; 159:9&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4882649</ArticleId><ArticleId IdType="pubmed">26590302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostick M., Jong J.K., Est&#xe8;ve P.O., Clark A., Pradhan S., Jacobsen S.E.. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science. 2007; 317:1760&#x2013;1764.</Citation><ArticleIdList><ArticleId IdType="pubmed">17673620</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama A., Yamaguchi L., Sharif J., Johmura Y., Kawamura T., Nakanishi K., Shimamura S., Arita K., Kodama T., Ishikawa F. et al. .. Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication. Nature. 2013; 502:249&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">24013172</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortusewicz O., Schermelleh L., Walter J., Cardoso M.C., Leonhardt H.. Recruitment of DNA methyltransferase I to DNA repair sites. Proc. Natl. Acad. Sci. U.S.A. 2005; 102:8905&#x2013;8909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1157029</ArticleId><ArticleId IdType="pubmed">15956212</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hagan H.M., Mohammad H.P., Baylin S.B.. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet. 2008; 4:e1000155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2491723</ArticleId><ArticleId IdType="pubmed">18704159</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G.E., Kim J.H., Taylor M., Muller M.T.. DNA methyltransferase 1-associated protein (DMAP1) is a co-repressor that stimulates DNA methylation globally and locally at sites of double strand break repair. J. Biol. Chem. 2010; 285:37630&#x2013;37640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2988368</ArticleId><ArticleId IdType="pubmed">20864525</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha K., Lee G.E., Palii S.S., Brown K.D., Takeda Y., Liu K., Bhalla K.N., Robertson K.D.. Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery. Hum. Mol. Genet. 2011; 20:126&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000680</ArticleId><ArticleId IdType="pubmed">20940144</ArticleId></ArticleIdList></Reference><Reference><Citation>Morano A., Angrisano T., Russo G., Landi R., Pezone A., Bartollino S., Zuchegna C., Babbio F., Bonapace I.M., Allen B. et al. .. Targeted DNA methylation by homology-directed repair in mammalian cells. Transcription reshapes methylation on the repaired gene. Nucleic Acids Res. 2014; 42:804&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3902918</ArticleId><ArticleId IdType="pubmed">24137009</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuozzo C., Porcellini A., Angrisano T., Morano A., Lee B., Di&#xa0;Pardo A., Messina S., Iuliano R., Fusco A., Santillo M.R. et al. .. DNA damage, homology-directed repair, and DNA methylation. PLoS Genet. 2007; 3:1144&#x2013;1162.</Citation></Reference><Reference><Citation>Russo G., Landi R., Pezone A., Morano A., Zuchegna C., Romano A., Muller M.T., Gottesman M.E., Porcellini A., Avvedimento E.V.. DNA damage and repair modify DNA methylation and chromatin domain of the targeted locus: Mechanism of allele methylation polymorphism. Sci. Rep. 2016; 6:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024116</ArticleId><ArticleId IdType="pubmed">27629060</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran F.A., Hsu P.D., Wright J., Agarwala V., Scott D.A., Zhang F.. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 2013; 8:2281&#x2013;2308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969860</ArticleId><ArticleId IdType="pubmed">24157548</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller J.C., Holmes M.C., Wang J., Guschin D.Y., Lee Y.-L., Rupniewski I., Beausejour C.M., Waite A.J., Wang N.S., Kim K.A. et al. .. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat. Biotechnol. 2007; 25:778&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pubmed">17603475</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohde C., Zhang Y., Reinhardt R., Jeltsch A.. BISMA - Fast and accurate bisulfite sequencing data analysis of individual clones from unique and repetitive sequences. BMC Bioinformatics. 2010; 11:230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2877691</ArticleId><ArticleId IdType="pubmed">20459626</ArticleId></ArticleIdList></Reference><Reference><Citation>Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L. et al. .. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991; 349:704&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">1671712</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen B., Pezone A., Porcellini A., Muller M.T., Masternak M.M.. Non-homologous end joining induced alterations in DNA methylation: A source of permanent epigenetic change. Oncotarget. 2017; 8:40359&#x2013;40372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5522286</ArticleId><ArticleId IdType="pubmed">28423717</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird P.W. Principles and challenges of genome-wide DNA methylation analysis. Nat. Rev. Genet. 2010; 11:191&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">20125086</ArticleId></ArticleIdList></Reference><Reference><Citation>Reckmann B., Krauss G.. The cleavage of single-stranded DNA by the isoschizomeric restriction endonuclease HhaI and CfoI. BBA - Gene Struct. Expr. 1987; 908:90&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">3026483</ArticleId></ArticleIdList></Reference><Reference><Citation>Lienert F., Wirbelauer C., Som I., Dean A., Mohn F., Sch&#xfc;beler D.. Identification of genetic elements that autonomously determine DNA methylation states. Nat. Genet. 2011; 43:1091&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">21964573</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahm J.Y., Kim J.Y., Park J.W., Kang J.Y., Kim K.B., Kim S.R., Cho H., Seo S.B.. Methylation of UHRF1 by SET7 is essential for DNA double-strand break repair. Nucleic Acids Res. 2019; 47:184&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6326791</ArticleId><ArticleId IdType="pubmed">30357346</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z., Zinman L., Moreno D., Schymick J., Liang Y., Sato C., Zheng Y., Ghani M., Dib S., Keith J. et al. .. Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. Am. J. Hum. Genet. 2013; 92:981&#x2013;989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675239</ArticleId><ArticleId IdType="pubmed">23731538</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagci H., Fisher A.G.. DNA demethylation in pluripotency and reprogramming: The role of tet proteins and cell division. Cell Stem Cell. 2013; 13:265&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">24012367</ArticleId></ArticleIdList></Reference><Reference><Citation>Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., Selkoe D.J.. Mutation of the &#x3b2;-amyloid precursor protein in familial Alzheimer's disease increases &#x3b2;-protein production. Nature. 1992; 360:672&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">1465129</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogaev E.I., Lukiw W.J., Lavrushina O., Rogaeva E.A., St.&#xa0;George-Hyslop P.H.. The upstream promoter of the &#x3b2;-amyloid precursor protein gene (app) shows differential patterns of methylation in human brain. Genomics. 1994; 22:340&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">7528717</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrachina M., Ferrer I.. DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. J. Neuropathol. Exp. Neurol. 2009; 68:880&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pubmed">19606065</ArticleId></ArticleIdList></Reference><Reference><Citation>Brohede J., Rinde M., Winblad B., Graff C.. A DNA methylation study of the amyloid precursor protein gene in several brain regions from patients with familial alzheimer disease. J. Neurogenet. 2010; 24:179&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">20919856</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata A., Nagata K., Hatsuta H., Takuma H., Bundo M., Iwamoto K., Tamaoka A., Murayama S., Saido T., Tsuji S.. Altered CpG methylation in sporadic alzheimer's disease is associated with APP and MAPT dysregulation. Hum. Mol. Genet. 2014; 23:648&#x2013;656.</Citation><ArticleIdList><ArticleId IdType="pubmed">24101602</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>